Subscribe
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
  • Videos
  • SABCS 2017

SABCS 2017

The Mechanism of Action of CDK4/6 Inhibitors
The Mechanism of Action of CDK4/6 Inhibitors
FEATURING:
Matthew P. Goetz, MD
Breast Cancer, SABCS 2017
Watch Video
The Use of Chemotherapy in the Metastatic Setting
The Use of Chemotherapy in the Metastatic Setting
FEATURING:
Matthew P. Goetz, MD
SABCS 2017, Breast Cancer, SABCS 2017
Watch Video
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
Abemaciclib, Ribociclib, or Palbociclib for HR+ Metastatic Breast Cancer?
FEATURING:
Matthew P. Goetz, MD
Breast Cancer, SABCS 2017, SABCS 2017
Watch Video
Questions About Treating Patients Using a CDK4/6 Inhibitor
Questions About Treating Patients Using a CDK4/6 Inhibitor
FEATURING:
Matthew P. Goetz, MD
SABCS 2017
Watch Video
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
CDK4/6 Inhibitors in HER2+ Metastatic Breast Cancer
FEATURING:
Matthew P. Goetz, MD
Breast Cancer, SABCS 2017
Watch Video
Hot Topics at SABCS 2017
Hot Topics at SABCS 2017
FEATURING:
Hope S. Rugo, MD
Breast Cancer, SABCS 2017
Watch Video
Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer
Why CDK4/6 Inhibitors Are Effective in HR-Positive Metastatic Breast Cancer
FEATURING:
Hope S. Rugo, MD
Breast Cancer, SABCS 2017
Watch Video
CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer
CDK4/6 Inhibitors vs Chemotherapy for Patients with Metastatic Breast Cancer
FEATURING:
Hope S. Rugo, MD
Breast Cancer, SABCS 2017
Watch Video
What Differentiates Abemaciclib, Ribociclib, and Palbociclib?
What Differentiates Abemaciclib, Ribociclib, and Palbociclib?
FEATURING:
Hope S. Rugo, MD
Breast Cancer, SABCS 2017
Watch Video
Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor
Disease Progression with a CDK4/6 Inhibitor plus an Aromatase Inhibitor
FEATURING:
Hope S. Rugo, MD
Breast Cancer, SABCS 2017
Watch Video
HER2-Positive Breast Cancer and CDK4/6 Inhibitors
HER2-Positive Breast Cancer and CDK4/6 Inhibitors
FEATURING:
Hope S. Rugo, MD
Breast Cancer, SABCS 2017
Watch Video

View the Latest Issue of OPM
View the Latest Issue
Read Issue

Top Trending Articles

1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By Dawn Holcombe, MBA, FACMPE, ACHE
2.
2023 Spotlight: Amgen
3.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By Dawn Holcombe, MBA, FACMPE, ACHE
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
CONNECT
Subscribe
  • About
    • About OPM
    • Mission Statement
    • Editorial Board
    • AOPM
    • Contact
  • Contribute
    • Submit a Manuscript
    • Author Guidelines
  • Connect
    • Join Us on LinkedIn
Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
© The Lynx Group, LLC. All Rights Reserved. Privacy Policy.